183 related articles for article (PubMed ID: 38177411)
1. The Wnt-pathway corepressor TLE3 interacts with the histone methyltransferase KMT1A to inhibit differentiation in Rhabdomyosarcoma.
Kalita B; Sahu S; Bharadwaj A; Panneerselvam L; Martinez-Cebrian G; Agarwal M; Mathew SJ
Oncogene; 2024 Feb; 43(7):524-538. PubMed ID: 38177411
[TBL] [Abstract][Full Text] [Related]
2. Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state.
Lee MH; Jothi M; Gudkov AV; Mal AK
Cancer Res; 2011 Jun; 71(11):3921-31. PubMed ID: 21493592
[TBL] [Abstract][Full Text] [Related]
3. Zeb1 and Tle3 are trans-factors that differentially regulate the expression of myosin heavy chain-embryonic and skeletal muscle differentiation.
Kumar P; Zehra A; Saini M; Mathew SJ
FASEB J; 2023 Aug; 37(8):e23074. PubMed ID: 37392376
[TBL] [Abstract][Full Text] [Related]
4. The transcriptional co-repressor TLE3 regulates myogenic differentiation by repressing the activity of the MyoD transcription factor.
Kokabu S; Nakatomi C; Matsubara T; Ono Y; Addison WN; Lowery JW; Urata M; Hudnall AM; Hitomi S; Nakatomi M; Sato T; Osawa K; Yoda T; Rosen V; Jimi E
J Biol Chem; 2017 Aug; 292(31):12885-12894. PubMed ID: 28607151
[TBL] [Abstract][Full Text] [Related]
5. Expression of TLE3 by bone marrow stromal cells is regulated by canonical Wnt signaling.
Kokabu S; Sato T; Ohte S; Enoki Y; Okubo M; Hayashi N; Nojima J; Tsukamoto S; Fukushima Y; Sakata Y; Katagiri T; Rosen V; Yoda T
FEBS Lett; 2014 Feb; 588(4):614-9. PubMed ID: 24444608
[TBL] [Abstract][Full Text] [Related]
6. p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program.
Chatterjee B; Wolff DW; Jothi M; Mal M; Mal AK
Skelet Muscle; 2016; 6():28. PubMed ID: 27551368
[TBL] [Abstract][Full Text] [Related]
7. Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells.
Wolff DW; Lee MH; Jothi M; Mal M; Li F; Mal AK
Oncotarget; 2018 May; 9(40):25796-25807. PubMed ID: 29899822
[TBL] [Abstract][Full Text] [Related]
8. RNF6 Promotes Colorectal Cancer by Activating the Wnt/β-Catenin Pathway via Ubiquitination of TLE3.
Liu L; Zhang Y; Wong CC; Zhang J; Dong Y; Li X; Kang W; Chan FKL; Sung JJY; Yu J
Cancer Res; 2018 Apr; 78(8):1958-1971. PubMed ID: 29374067
[TBL] [Abstract][Full Text] [Related]
9. TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis.
Anstine LJ; Majmudar PR; Aponte A; Singh S; Zhao R; Weber-Bonk KL; Abdul-Karim FW; Valentine M; Seachrist DD; Grennel-Nickelson KE; Cuellar-Vite L; Sizemore GM; Sizemore ST; Webb BM; Thompson CL; Keri RA
Cancer Res; 2023 Apr; 83(7):997-1015. PubMed ID: 36696357
[TBL] [Abstract][Full Text] [Related]
10. HHEX suppresses advanced thyroid cancer by interacting with TLE3.
Xu Z; Feng Y; Yan Y; Jin H; Chen Y; Han Y; Huang S; Feng F; Fu H; Yin Y; Huang Y; Wang H; Cheng W
Mol Cell Endocrinol; 2023 Aug; 574():111988. PubMed ID: 37302518
[TBL] [Abstract][Full Text] [Related]
11. Differential Regulation of
Lee S; Jang H; Moon S; Lee OH; Lee S; Lee J; Park C; Seol DW; Song H; Hong K; Kim JH; Uhm SJ; Lee DR; Lee JW; Choi Y
Cells; 2019 Sep; 8(10):. PubMed ID: 31569653
[TBL] [Abstract][Full Text] [Related]
12. TLE3 is a dual-function transcriptional coregulator of adipogenesis.
Villanueva CJ; Waki H; Godio C; Nielsen R; Chou WL; Vargas L; Wroblewski K; Schmedt C; Chao LC; Boyadjian R; Mandrup S; Hevener A; Saez E; Tontonoz P
Cell Metab; 2011 Apr; 13(4):413-427. PubMed ID: 21459326
[TBL] [Abstract][Full Text] [Related]
13. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
14. Transducin-like enhancer of split 3 (TLE3) in adipose tissue is increased in situations characterized by decreased PPARγ gene expression.
Ortega FJ; Serrano M; Rodriguez-Cuenca S; Moreno-Navarrete JM; Gómez-Serrano M; Sabater M; Rodriguez-Hermosa JI; Xifra G; Ricart W; Peral B; Vidal-Puig A; Fernández-Real JM
J Mol Med (Berl); 2015 Jan; 93(1):83-92. PubMed ID: 25249007
[TBL] [Abstract][Full Text] [Related]
15. A GRIP-1-EZH2 switch binding to GATA-4 is linked to the genesis of rhabdomyosarcoma through miR-29a.
Song YL; Yang MH; Zhang S; Wang H; Kai KL; Yao CX; Dai FF; Zhou MJ; Li JB; Wei ZR; Yin Z; Zhu WG; Xue L; Zang MX
Oncogene; 2022 Dec; 41(49):5223-5237. PubMed ID: 36309571
[TBL] [Abstract][Full Text] [Related]
16. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
[TBL] [Abstract][Full Text] [Related]
17. Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.
Simeoni F; Romero-Camarero I; Camera F; Amaral FMR; Sinclair OJ; Papachristou EK; Spencer GJ; Lie-A-Ling M; Lacaud G; Wiseman DH; Carroll JS; Somervaille TCP
Cell Rep; 2021 Sep; 36(12):109725. PubMed ID: 34551306
[TBL] [Abstract][Full Text] [Related]
18. Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice.
Singh S; Vinson C; Gurley CM; Nolen GT; Beggs ML; Nagarajan R; Wagner EF; Parham DM; Peterson CA
Am J Pathol; 2010 Oct; 177(4):2055-66. PubMed ID: 20829439
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional co-repressor TLE3 regulates development of trophoblast giant cells lining maternal blood spaces in the mouse placenta.
Gasperowicz M; Surmann-Schmitt C; Hamada Y; Otto F; Cross JC
Dev Biol; 2013 Oct; 382(1):1-14. PubMed ID: 23954203
[TBL] [Abstract][Full Text] [Related]
20. TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways.
Yang RW; Zeng YY; Wei WT; Cui YM; Sun HY; Cai YL; Nian XX; Hu YT; Quan YP; Jiang SL; Wang M; Zhao YL; Qiu JF; Li MX; Zhang JH; He MR; Liang L; Ding YQ; Liao WT
J Exp Clin Cancer Res; 2016 Sep; 35(1):152. PubMed ID: 27669982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
